Safinamide Phase III Study Results Presented at 2013 MDS Meeting MILAN, June 19, 2013 /PRNewswire/ -- Safinamide significantly improves responder rates in fluctuating Parki n son's disease (PD) patients as add-on to levodopa Safinamide is associated with clinically ...
June 19, 2013 - PR Newswire via Yahoo! Finance